Amarantus Bioscience Holdings Inc (AMBS)

[Voices of Reason]

"...then this stock will one day be very rewarding either from a buyout or from AMBS getting funding to advance their clinical trials."

I would think that most would agree that a buyout isn't going to happen without clinical trials. Regarding funding to advance the clinical trials, what steeply discounted convertible stock price would you consider rational for a venture capitalist to risk considering the stock has gone from $1.50 to $0.01 in the last year? How much money would that take to perform the trials?